Cargando…

Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report

BACKGROUND: Kratom is a psychoactive plant preparation originating from Southeast Asia. It has been used as a recreational and performance drug in Southeast Asia, and is now increasingly used in Europe and the U.S. CASE REPORT: We describe the case of a 63-year-old man who presented for treatment af...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Elisabeth, Hillemacher, Thomas, Müller, Christian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180622/
https://www.ncbi.nlm.nih.gov/pubmed/34136676
http://dx.doi.org/10.1016/j.heliyon.2021.e07039
_version_ 1783704031627051008
author Müller, Elisabeth
Hillemacher, Thomas
Müller, Christian P.
author_facet Müller, Elisabeth
Hillemacher, Thomas
Müller, Christian P.
author_sort Müller, Elisabeth
collection PubMed
description BACKGROUND: Kratom is a psychoactive plant preparation originating from Southeast Asia. It has been used as a recreational and performance drug in Southeast Asia, and is now increasingly used in Europe and the U.S. CASE REPORT: We describe the case of a 63-year-old man who presented for treatment after his long-term Kratom use failed as a self-management for persistent major depression (ICD 10: F33.2) and a generalized anxiety disorder (ICD-10: F41.1). The failure coincided with emerging stress at the beginning of the COVID-19 pandemic. The patient suffered from childhood on from ruminative thinking and depressive mood, which was treated in several settings during his life. He started to use alcohol to control his depression, but developed an alcohol addiction. This was successfully treated and the patient remained abstinent for more than 25 years afterwards. About 7 years ago, he started to use Kratom 3–4 times daily on a regular, but constant rate. Kratom use worked efficiently as a self-management of his depression with no escalation of dosing. It was also very effective in reducing Morbus Menière symptoms of tinnitus and sudden hearing loss, which eventually allowed regular performance as a caregiver in a demanding job on shift-work. During recently increased stress load in the work environment and the COVID-19 pandemic, the established Kratom doses failed to control hyperarousal and mental nervousness. The patient was treatment seeking and subsequently detoxified from Kratom. Anxiety- and depression management was shifted to treatment attempts with Lorazepam, Venlafaxine, Opipramol, Mirtazapine and psychotherapy. CONCLUSION: Kratom instrumentalization for self-management of depression and anxiety may effectively work without causing escalation of drug use and addiction, but may be limited by a temporary increase in psychological stress load and a relapse into major depression and generalized anxiety disorder.
format Online
Article
Text
id pubmed-8180622
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81806222021-06-15 Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report Müller, Elisabeth Hillemacher, Thomas Müller, Christian P. Heliyon Case Report BACKGROUND: Kratom is a psychoactive plant preparation originating from Southeast Asia. It has been used as a recreational and performance drug in Southeast Asia, and is now increasingly used in Europe and the U.S. CASE REPORT: We describe the case of a 63-year-old man who presented for treatment after his long-term Kratom use failed as a self-management for persistent major depression (ICD 10: F33.2) and a generalized anxiety disorder (ICD-10: F41.1). The failure coincided with emerging stress at the beginning of the COVID-19 pandemic. The patient suffered from childhood on from ruminative thinking and depressive mood, which was treated in several settings during his life. He started to use alcohol to control his depression, but developed an alcohol addiction. This was successfully treated and the patient remained abstinent for more than 25 years afterwards. About 7 years ago, he started to use Kratom 3–4 times daily on a regular, but constant rate. Kratom use worked efficiently as a self-management of his depression with no escalation of dosing. It was also very effective in reducing Morbus Menière symptoms of tinnitus and sudden hearing loss, which eventually allowed regular performance as a caregiver in a demanding job on shift-work. During recently increased stress load in the work environment and the COVID-19 pandemic, the established Kratom doses failed to control hyperarousal and mental nervousness. The patient was treatment seeking and subsequently detoxified from Kratom. Anxiety- and depression management was shifted to treatment attempts with Lorazepam, Venlafaxine, Opipramol, Mirtazapine and psychotherapy. CONCLUSION: Kratom instrumentalization for self-management of depression and anxiety may effectively work without causing escalation of drug use and addiction, but may be limited by a temporary increase in psychological stress load and a relapse into major depression and generalized anxiety disorder. Elsevier 2021-05-10 /pmc/articles/PMC8180622/ /pubmed/34136676 http://dx.doi.org/10.1016/j.heliyon.2021.e07039 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Müller, Elisabeth
Hillemacher, Thomas
Müller, Christian P.
Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report
title Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report
title_full Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report
title_fullStr Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report
title_full_unstemmed Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report
title_short Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report
title_sort kratom use for depression/anxiety self-management: challenges during the covid-19 pandemic – a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180622/
https://www.ncbi.nlm.nih.gov/pubmed/34136676
http://dx.doi.org/10.1016/j.heliyon.2021.e07039
work_keys_str_mv AT mullerelisabeth kratomusefordepressionanxietyselfmanagementchallengesduringthecovid19pandemicacasereport
AT hillemacherthomas kratomusefordepressionanxietyselfmanagementchallengesduringthecovid19pandemicacasereport
AT mullerchristianp kratomusefordepressionanxietyselfmanagementchallengesduringthecovid19pandemicacasereport